Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
77.31
-0.49 (-0.63%)
Aug 5, 2026, 12:16 PM EDT - Market open

Disc Medicine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-269.27-236.02-129.72-91.13-47.48-30.93
Net Income
-245.89-212.18-109.36-76.43-46.83-35.97
Earnings Per Share
-6.58-6.01-3.96-3.42-45.05-40.95
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
717.75791.15489.88360.38194.6188.04
Total Debt
60.8631.02302.11.331.65
Net Cash (Debt)
656.88760.13459.88358.28193.2886.38
Net Cash Growth
6.11%65.29%28.36%85.37%123.74%-
Net Cash Per Share
17.5221.5416.6616.05185.9398.34

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-197.54-180.39-93.93-73.46-42.25-27.53
Capital Expenditures
-0.05-0.93-0.51-0.09-0.15-0.07
Free Cash Flow
-197.58-181.33-94.43-73.55-42.4-27.6
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.